Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 4, 2014, Pages 1208-1216.e2

  Pei, Bao Xiang ^a   Sun, Bing Sheng ^a   Zhang, Zhen Fa ^a   Wang, An Lei ^a   Ren, Peng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 6; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG RESECTION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PHENOTYPE; PROTEIN EXPRESSION; STROMA CELL; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; AGED; ENZYME IMMUNOASSAY; LUNG ALVEOLUS MACROPHAGE; LUNG TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; RISK FACTOR;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; LUNG NEOPLASMS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908243244     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.05.003     Document Type: Article

References (35)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. D. Fahham, I.D. Weiss, M. Abraham, K. Beider, W. Hanna, and Z. Shlomez In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer J Thorac Cardiovasc Surg 144 2012 1167 1175
3. K. Miyoshi, S. Moriyama, T. Kunitomo, and S. Nawa Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 429 434
4. M. Reck, D.F. Heigener, T. Mok, J.C. Soria, and K.F. Rabe Management of non-small-cell lung cancer: recent developments Lancet 382 2013 709 719
5. J.M. Varlotto, A. Recht, J.C. Flickinger, L.N. Medford-Davis, A.M. Dyer, and M.M. Decamp Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer Cancer 115 2009 1059 1069
6. D. Rinewalt, D.D. Shersher, S. Daly, C. Fheid, S. Basu, and B. Mahon Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients J Thorac Cardiovasc Surg 144 2012 1344 1350
7. T. Hagemann, J. Wilson, F. Burke, H. Kulbe, N.F. Li, and A. Plüddemann Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype J Immunol 176 2006 5023 5032
8. F. Balkwill, K.A. Charles, and A. Mantovani Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 2005 211 217
9. M. Becker, C.B. Müller, M.A. De Bastiani, and F. Klamt The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer Histol Histopathol 29 2014 21 31
10. P. da Costa Souza, E.R. Parra, M.J. Atanazio, O.B. da Silva, G.S. Noleto, and A.M. Ab'saber Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma Histopathology 61 2012 587 596
11. D.W. Kim, H.S. Min, K.H. Lee, Y.J. Kim, D.Y. Oh, and Y.K. Jeon High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Br J Cancer 98 2008 1118 1124
12. T.J. Welsh, R.H. Green, D. Richardson, D.A. Waller, K.J. O'Byrne, and P. Bradding Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer J Clin Oncol 23 2005 8959 8967
13. K. Kawamura, Y. Komohara, K. Takaishi, H. Katabuchi, and M. Takeya Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors Pathol Int 59 2009 300 305
14. D. Duluc, Y. Delneste, F. Tan, M.P. Moles, L. Grimaud, and J. Lenoir Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells Blood 110 2007 4319 4330
15. A. Sica, P. Larghi, A. Mancino, L. Rubino, A. Porta, and M.G. Totaro Macrophage polarization in tumour progression Semin Cancer Biol 18 2008 349 355
16. J. Kaminska, M. Kowalska, B. Kotowicz, M. Fuksiewicz, M. Glogowski, and E. Wojcik Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor Oncology 70 2006 115 125
17. H. Kita, Y. Shiraishi, K. Watanabe, K. Suda, K. Ohtsuka, and Y. Koshiishi Does postoperative serum interleukin-6 influence early recurrence after curative pulmonary resection of lung cancer? Ann Thorac Cardiovasc Surg 17 2011 454 460
18. R.A. Salgado, A. Snoeckx, M. Spinhoven, B. Op de Beeck, B. Corthouts, and P.M. Parizel Update in non small-cell lung cancer staging JBR-BTR 96 2013 118 122
19. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat Rev Cancer 4 2004 71 78
20. R. Wang, J. Zhang, S. Chen, M. Lu, X. Luo, and S. Yao Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression Lung Cancer 74 2011 188 196
21. J.J. Chen, P.L. Yao, A. Yuan, T.M. Hong, C.T. Shun, and M.L. Kuo Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer Clin Cancer Res 9 2003 729 737
22. A. Sica, P. Allavena, and A. Mantovani Cancer related inflammation: the macrophage connection Cancer Lett 267 2008 204 215
23. T. Lucas, D. Abraham, and S. Aharinejad Modulation of tumor associated macrophages in solid tumors Front Biosci 13 2008 5580 5588
24. A. Sica, and V. Bronte Altered macrophage differentiation and immune dysfunction in tumor development J Clin Invest 117 2007 1155 1166
25. B. Kascinski Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms Cancer Treat Res 107 2002 285 292
26. C. Jones, and S. Ricardo Macrophages and CSF-1: implications for development and beyond Organogenesis 9 2013 249 260
27. J.M. Curry, T.D. Eubank, R.D. Roberts, Y. Wang, N. Pore, and A. Maity M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo PLoS One 3 2008 e3405
28. D.R. Hodge, E.M. Hurt, and W.L. Farrar The role of IL-6 and STAT3 in inflammation and cancer Eur J Cancer 41 2005 2502 2512
29. E.M. Dijkgraaf, M.J. Welters, J.W. Nortier, S.H. van der Burg, and J.R. Kroep Interleukin-6/IL-6 receptor pathway as a new therapy target in epithelial ovarian cancer Curr Pharm Des 18 2012 3816 3827
30. B.E. Lippitz Cytokine patterns in patients with cancer: a systematic review Lancet Oncol 14 2013 e218 e228
31. E.M. Dijkgraaf, M. Heusinkveld, B. Tummers, L.T. Vogelpoel, R. Goedemans, and V. Jha Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor micro-environment Cancer Res 73 2013 2480 2492
32. S. Goswami, E. Sahai, J.B. Wyckoff, M. Cammer, D. Cox, and F.J. Pixley Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop Cancer Res 65 2005 5278 5283
33. Y. Yang, J. Qin, L. Lan, N. Li, C. Wang, and P. He M-CSF cooperating with NF-kB induces macrophage transformation from M1 to M2 by up-regulating c-Jun Cancer Biol Ther 15 2014 99 107
34. 2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells J Immunol 187 2011 1157 1165
35. T.L. Rogers, and I. Holen Tumour macrophages as potential targets of bisphosphonates J Transl Med 9 2011 177